Safety, pharmacokinetics, and antiviral activity of RO7049389, an allosteric core protein modulator, in patients with chronic hepatitis B virus infection: a multicenter, randomized, placebo-controlled…
MSD Announces US Government Supply Agreement for Molnupiravir, an oral antiviral investigational candidate for the treatment of mild to moderate COVID-19 PRNewswire